NCT06746376

Brief Summary

This study aims to evaluate the impact of a 12-week hand exercise program on pain, manual dexterity, and hand function in women experiencing hand joint pain (arthralgia) due to hormone therapy after breast cancer. Participants will be randomly assigned to either an intervention group, where they will perform specific hand exercises, or a control group, which will not receive any exercise program. Pain levels, hand function, and manual dexterity will be assessed before and after the intervention using questionnaires and functional tests. The goal is to determine whether targeted hand exercises can improve pain and daily hand use in this population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 24, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

December 24, 2024

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

December 17, 2024

Last Update Submit

December 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Brief Pain Inventory (BPI)

    A validated tool used to assess the severity of pain and its impact on daily functioning. Participants will report pain intensity on a numeric scale and describe how pain interferes with their daily life activities.

    Pre Intervention and after the 8 weeks intervention

Secondary Outcomes (6)

  • DASH (Disabilities of the Arm, Shoulder, and Hand) Questionnaire

    Pre Intervention and after the 8 weeks intervention

  • McCaffrey's Initial Pain Assessment Tool

    Pre Intervention and after the 8 weeks intervention

  • ABILHAND Questionnaire

    Pre Intervention and after the 8 weeks intervention

  • Purdue Pegboard Test

    Pre Intervention and after the 8 weeks intervention

  • Box and Block Test

    Pre Intervention and after the 8 weeks intervention

  • +1 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Description: Participants assigned to the intervention group will undergo a 8-week supervised hand exercise program designed to improve pain, manual dexterity, and functionality. Sessions will last 45 minutes and occur once per week under the supervision of a qualified occupational therapist and one self-administrated home exercise session. The program includes three structured phases per session Warm-Up Phase (10 minutes) Gentle hand and wrist stretches Main Exercise Phase (25 minutes) This phase focuses on strengthening, manual dexterity, and functional tasks: Strengthening Exercises Manual Dexterity Exercises Functional Tasks (Simulated Activities of Daily Living - AVDs): Cool-Down Phase (10 minutes) 8 weeks, with 45-minute sessions twice weekly.

Other: Occupational Therapy

Control

NO INTERVENTION

Description: Participants in the control group will not receive any intervention during the study period. They will undergo the same assessments as the intervention group at baseline and after 8 weeks to evaluate changes over time. Details: The control group will serve as a comparison to determine the effects of time alone on pain, manual dexterity, and hand functionality in women with hormone therapy-related arthralgia. Participants will continue their usual daily activities and standard care during the study period. No specific exercises or additional therapies will be provided as part of the study.

Interventions

Description: Participants assigned to the intervention group will undergo a 8-week supervised hand exercise program designed to improve pain, manual dexterity, and functionality.

Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Experiencing hand arthralgia as a result of hormone therapy (aromatase inhibitors or tamoxifen) following breast cancer.
  • Ability to communicate pain levels effectively. Ability to follow simple instructions to participate in the intervention and assessments.

You may not qualify if:

  • Concurrent physiotherapy or occupational therapy specifically targeting the hand during the study.
  • Pre-existing diagnosis of arthritis or osteoarthritis in the hand before starting hormone therapy.
  • Presence of systemic diseases associated with hand arthralgia. Neurological conditions affecting hand movement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Europea de Madrod

Villaviciosa de Odón, Spain

Location

MeSH Terms

Conditions

Arthralgia

Interventions

Occupational Therapy

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • Vanesa Abuín-Porras, PhD

    Universidad Europea de Madrid

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vanesa Abuín-Porras, PhD

CONTACT

Nuria Muñoz-Bermúdez, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The evaluator will be blinded to the patient's allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asistant Professor

Study Record Dates

First Submitted

December 17, 2024

First Posted

December 24, 2024

Study Start

April 1, 2025

Primary Completion

October 1, 2025

Study Completion

November 1, 2025

Last Updated

December 24, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations